Effects of Chronic Dosage with Chlorpromazine and Gerovital H3 in the Aging Brain
Aging may be considered a progressive deterioration of an organism after maturation that leads to physiological decline, increasing incidence of pathological lesions, and death. The rate of aging and duration of life appear to result from an interaction between the genetic program in the cell and influences from the external environment. While the causes of aging are unknown, there is evidence that the rate of aging may be mediated by the brain, especially by the hypothalamus and the closely linked pituitary and peripheral endocrine system (Everitt, 1976). Disproportionate changes in this system may result in “disregulation” of the organism (Frolkis, 1976), or an elevation of hypothalamic threshold to feed back control (Dilman, 1971), which in turn cause the development of age-related pathology.
KeywordsPigment Granule Spontaneous Locomotor Activity Procaine Hydrochloride Chronic Dosage Lipofuscin Pigment
Unable to display preview. Download preview PDF.
- Everitt, A.V. The nature and measurment of aging. In: Hypothalamus, Pituitary and Aging, (Eds. A.V. Everitt and J.A. Burgess), Charles C. Thomas, Springfield, Ill, p. 5, 1976.Google Scholar
- Frolkis, V.V. The hypothalamic mechanisms of aging. In: Hypothalamus, Pituitary and Aging, (Eds. A.V. Everitt and J.A. Burgess), Charles C. Thomas, Springfield, Ill., p. 614, 1976.Google Scholar
- Gordon, P. Free radicals and the aging process. In: Theoretical Aspects of Aging, (Ed. M. Rockstein), Academic Press, New York, p. 61, 1974.Google Scholar
- Himwich, H.E. Tranquilizers, barbiturates, and the brain. J. Neuropsychiat. 3:279, 1962.Google Scholar
- Hochschild, R. Effects of DMAE on depression, on in vitro cell survival and on animal life span. In: Procaine and Related Geropharmacologic Agents — The Current State-of-the-Art, (Eds. A. Cherkin and M.A.P. Sviland), VA GRECC Monograph No. 1, p. 27, 1975.Google Scholar
- Kohn, R.R. Aging of animals: Observations and questions. In: Principles of Mammalian Aging, Prentice-Hall, Englewood Cliffs, New Jersey, p. 105, 1971.Google Scholar
- Pfeiffer, C.C. and Murphree, H.B. Stimulant effect of 2-dimethylaminoethanol in human subjects. J. Pharmacol. Exp. Ther. 122: 60A, 1958.Google Scholar
- Samorajski, T. Age-related changes in brain biogenic amines. In: Aging Vol. 1, (Eds. H. Brody, D. Harman and J.M. Ordy), Raven Press, New York, p. 199, 1975.Google Scholar
- Zuckerman, B.M., Nelson, B. and Kisiel, M. Specific gravity increase of Caenorhabditis briggsae with age. J. Nematology vn4:261, 1972.Google Scholar
- Zung, W.K. Treatment of depression in the aged with Gerovital H3: Clinical efficacy and neurophysiological correlation. In: Procaine and Related Geropharmacologic Agents — The Current State-of-the-Art, (Eds. A. Cherkin and M.A.P. Sviland), VA GRECC Monograph No. 1, p. 53, 1975.Google Scholar